中广核核技术发展股份有限公司 关于控股股东向公司子公司增资事项完成工商变更 登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 证券代码：000881 证券简称：中广核技 公告编号：2025-035 许可项目：第二类医疗器械生产；第三类医疗器械生产；第三类医疗器械经 营；Ⅰ类射线装置销售；Ⅱ、Ⅲ类射线装置销售；Ⅱ、Ⅲ类射线装置生产；货物 进出口；技术进出口；进出口代理（依法须经批准的项目，经相关部门批准后方 可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准） 一般项目：机械设备研发；第一类医疗器械生产；第一类医疗器械销售；第 二类医疗器械销售；技术服务、技术开发、技术咨询、技术交流、技术转让、技 术推广；信息技术咨询服务；电子专用设备制造；电子元器件零售；先进电力电 子装置销售；电子专用材料销售；电气设备销售；电气机械设备销售（除依法须 经批准的项目外，凭营业执照依法自主开展经营活动）。 近日，核技术公司已向医疗科技公司以现金方式增资 5 亿元，医疗科技公司 已办理完成工商变更登记手续并取得了换发后的《营业执照》。 1.名称：中广核医疗科 ...

Economic News - In June, the total electricity consumption in China reached 867 billion kWh, a year-on-year increase of 5.4% [1] - The People's Bank of China announced that the 5-year LPR remains at 3.5% and the 1-year LPR at 3% [1] - The U.S. government is reviewing contracts between SpaceX and federal agencies due to concerns over potential waste in multi-billion dollar deals [1] - The Ministry of Transport reported that several key indicators of the "14th Five-Year Plan" have been completed ahead of schedule, including highway mileage and urban rail transit [1] - E-commerce in China saw a growth of 8.5% in online retail sales from January to June 2025, with significant increases in digital products and home appliances [1] - The Ministry of Industry and Information Technology is set to release a plan to stabilize growth in ten key industries, including steel and non-ferrous metals [1] - The European Investment Bank will launch a financing support plan totaling €4.25 billion for renewable energy and green technology investments in EU countries [1] Company News - Yushutech has begun its IPO counseling process with CITIC Securities as the advisor, aiming to submit its application by October 2025 [4] - Suzhou Goodark has been established in Singapore with an investment of approximately 8 million RMB for electronic materials and solar cell production [4] - Hongxin Technology signed contracts with a leading domestic flying car company for the development and procurement of components, which is expected to positively impact its performance [4] - Rainbowsoft's chairman proposed a cash dividend plan for 2025, suggesting a distribution of no less than 60% of the net profit attributable to shareholders [4] - Changyingtong expects revenue between 173 million to 211 million RMB for the first half of 2025, with a significant increase in net profit due to rising demand for optical fiber devices [4] Retail Industry - In June 2025, the total retail sales of consumer goods grew by 4.8% year-on-year, with a slowdown attributed to the earlier "618" shopping festival and weaker restaurant sales [5][6] - Essential consumption remains stable, while optional categories show a slowdown in recovery, with food and daily necessities performing well [6] - Home appliances and furniture sales saw significant growth, with home appliances up 32.4% and furniture up 28.7% year-on-year, driven by government policies [7] - Online retail sales increased by 8.5% in the first half of 2025, with physical goods online sales growing by 6.0%, indicating a steady growth in online consumption [8] - The retail market is expected to continue its recovery, with a focus on durable goods benefiting from policy support and consumer preferences for high-cost performance products [8]

中广核核技术发展股份有限公司 董事会 2025 年 7 月 17 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 中广核核技术发展股份有限公司（以下简称"公司"）于 2025 年 7 月 16 日 收到公司总法律顾问陈刚先生提交的书面辞职报告，陈刚先生由于工作调整，申 请辞去总法律顾问、总经济师，辞职后仍在公司承担其它专项工作。根据《公司 法》《公司章程》的有关规定，陈刚先生的辞职报告自送达公司董事会之日起生 效。截至本公告披露日，陈刚先生未持有公司股份，但持有公司《股票期权激励 计划》授予的 186,667 份股票期权（激励对象发生职务变更，但未与公司解除或 终止劳动关系的，其获授的股票期权完全按照职务变更前激励计划规定的程序进 行），不存在应当履行而未履行的承诺事项。 公司董事会对陈刚先生在任职期间为公司发展所做出的贡献表示衷心感谢！ 特此公告。 证券代码：000881 证券简称：中广核技 公告编号：2025-034 中广核核技术发展股份有限公司 关于公司总法律顾问辞职的公告 ...

证券代码：000881 证券简称：中广核技 公告编号：2025-033 3.本次会议应出席董事 9 名，实际出席董事 9 名（其中：委托出席的董事 0 名，以通讯表决方式出席会议的董事 6 名，分别为何飞、慕长坤、吴远明、黄晓 延、康晓岳、王满）。 4.本次会议由公司董事长盛国福先生主持。公司董事会秘书及部分高管人员 列席会议。 5.本次会议的召集、召开符合有关法律、行政法规、部门规章、规范性文件 和《公司章程》的规定。 中广核核技术发展股份有限公司 第十届董事会第二十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 一、董事会会议召开情况 1.中广核核技术发展股份有限公司（以下简称"公司"）第十届董事会第二 十九次会议（以下简称"本次会议"）通知于 2025 年 7 月 8 日以电子邮件形式 发出。 2.本次会议于 2025 年 7 月 14 日上午 9:00 在深圳市福田区深南大道 2002 号 中广核大厦北楼 19 层 881 会议室以现场结合通讯表决方式召开。 表决情况：9 票同意、0 票反对、0 票弃权、0 票回避 二、董事会会议审 ...

CGNNT 总经理工作细则 版次：4 页：1/7 067-GN-P-TD-B21-124 中广核核技术发展股份有限公司 总经理工作细则 第一章 总则 第一条 为深入贯彻习近平新时代中国特色社会主义思想，把加强党的领导和完善公司治理 统一起来，深化中国特色现代企业制度建设，加快形成权责法定、权责透明、协调运转、有效 制衡的公司治理机制，提高决策效率和科学决策水平，规范中广核核技术发展股份有限公司（以 下简称"公司"）总经理及其他经营层成员依法行使职权、履行职责，根据《中华人民共和国公 司法》、《上市公司治理准则》以及《中广核核技术发展股份有限公司公司章程》（以下简称《公 司章程》）等相关规定，特制定本工作细则。 第二条 公司依据《公司章程》设置总经理一名，由董事长提名，由董事会聘任或解聘。公 司总经理对董事会负责，根据公司章程的规定或者董事会的授权行使职权。总经理列席董事会 会议。 第二章 总经理任职资格 第三条 总经理任职应当具备下列条件： （一）具有较丰富的经济理论知识、管理知识及实践经验，具有较强的经营管理能力； （二）具有调动员工积极性、建立合理的组织机构、协调各种内外关系和统揽全局的能力； （三）具有 ...

度报告为准，敬请广大投资者注意投资风险。 | 证券代码：000881 证券简称：中广核技 公告编号：2025-032 | | | | | | --- | --- | --- | --- | --- | | 中广核核技术发展股份有限公司 | | | | | | 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 | | | | | | 导性陈述或者重大遗漏。 | | | | | | 一、本期业绩预计情况 | | | | | | （一）业绩预告期间 | | | | | | （二）业绩预告情况 | | | | | | ? 预计净利润为负值 | | | | | | 项 目 本报告期 上年同期 | | | | | | 归属于上市公司 | | | | | | 亏损：9,000.00 亏损：8,657.78 | 万元至 | 12,000.00 | 万元 | 万元 | | 股东的净利润 | | | | | | 归属于上市公司 | | | | | | 股东的扣除非经 | | | | | | 亏损：10,000.00 万元至 13,000.00 亏损：13,147.08 | | | 万元 | 万元 | | ...

[Estimated Performance for the Current Period](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company projects a net loss attributable to shareholders for H1 2025, with non-recurring net loss expected to narrow compared to the prior year - The performance forecast covers the period from January 1, 2025, to June 30, 2025[2](index=2&type=chunk) Key Financial Performance Indicators | Item | Current Period (Jan 1 - Jun 30, 2025) | Prior Period | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Loss: RMB 90.00 million to RMB 120.00 million | Loss: RMB 86.5778 million | | **Net Profit After Non-Recurring Items** | Loss: RMB 100.00 million to RMB 130.00 million | Loss: RMB 131.4708 million | | **Basic Earnings Per Share** | Loss: RMB 0.0952/share to RMB 0.1269/share | Loss: RMB 0.0916/share | [Communication with Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The performance forecast data is a preliminary estimate by the company and has not been audited by a certified public accountant - This performance forecast has not been audited by a certified public accountant[3](index=3&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) Despite growth in new materials, overall performance fell short due to increased R&D investment in early-stage medical health and silicon photomultiplier businesses, temporary losses in accelerator operations, and a significant decrease in non-recurring government subsidies - Overall company performance fell short of expectations, primarily impacted by the following business areas: - **Medical Health Business**: Still in its early industrialization phase, current period losses expanded year-over-year due to increased investment in proton therapy equipment market expansion, core technology R&D, and isotope business layout[4](index=4&type=chunk) - **Silicon Photomultiplier Business**: In its incubation phase, it has not yet achieved profitability due to continuous investment in independent breakthroughs for critical product components and improvements in production line yield[4](index=4&type=chunk) - **Accelerator and Irradiation Business**: Due to adjustments in some client delivery schedules, the number of accelerator deliveries decreased year-over-year, resulting in a temporary loss during the reporting period[5](index=5&type=chunk) - **Non-Recurring Gains and Losses**: Government subsidies recognized in current period profit and loss significantly decreased year-over-year, leading to a substantial decline in non-recurring items compared to the prior period[5](index=5&type=chunk) [Risk Warning](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company advises that this performance forecast is preliminary, and final financial data will be based on the officially disclosed 2025 semi-annual report, cautioning investors about investment risks - This performance forecast is a preliminary estimate, and the specific financial data will be subject to the company's upcoming 2025 semi-annual report[6](index=6&type=chunk)

Group 1 - The company China General Nuclear Power Technology (中广核技) expects a net profit loss of 90 million to 120 million yuan in the first half of 2025, compared to a loss of 86.5778 million yuan in the same period last year [1]

Core Viewpoint - The Mianyang Nuclear Medical Health Industrial Park has signed 28 projects with a total investment of 22.3 billion yuan, indicating a strong interest in the nuclear medical sector in Mianyang [4][12]. Investment and Development - Recent capital movements in the nuclear medical sector include the completion of A+ round financing by Guotong New Drug, and the listing application by Xiantong Pharmaceutical on the Hong Kong Stock Exchange [2][3]. - The Mianyang Nuclear Medical Health Industrial Park has attracted significant investment, with 28 projects signed and a total investment amounting to 223 billion yuan [4][12]. Technological Advancements - The park features advanced radiation therapy technologies, including the X-Flash and e-Flash devices, which utilize Flash radiation therapy to significantly reduce treatment time while maintaining efficacy [6][8]. - The first domestic proton therapy device is set to be produced in Mianyang, with a production base for proton equipment expected to be completed by June 2024 [9][11]. Supply Chain and Resource Availability - Mianyang has become a major supplier of medical isotopes, with a focus on the production of iodine-131 and lutetium-177, which are critical for nuclear medicine [11][24]. - The proximity of Xiantong Pharmaceutical to the isotope production base enhances supply convenience, making Mianyang an attractive location for nuclear medicine companies [11][12]. Collaborative Efforts and Government Support - The rapid development of the nuclear medical industrial park is supported by collaborations between enterprises and research institutions, as well as government initiatives [12][15]. - The local government has committed over 13 billion yuan in special bonds and guiding funds to support infrastructure and research projects in the nuclear medical sector [27]. Talent and Research Development - Mianyang has a strong talent pool, with significant investments in education and research institutions focused on nuclear science and technology [23][24]. - The establishment of key laboratories and research platforms in Mianyang aims to address critical challenges in nuclear technology applications [26].

Core Insights - The report highlights the impact of the recent US-Vietnam trade agreement on China's textile exports, with US tariffs on Vietnam reduced from 46% to 20%, potentially leading to a shift of orders from US buyers to Vietnam [8] - The outdoor industry is expected to continue thriving, supported by increasing participation in events and a growing market for outdoor products, with a target industry scale exceeding 3 trillion yuan by 2025 [9] - The real estate market is anticipated to stabilize, with potential policy support from the government, which may positively influence the home furnishing sector [10] Economic News - The National Development and Reform Commission has allocated an additional 10 billion yuan for employment projects, expected to create jobs for 310,000 individuals [2] - The People's Bank of China is exploring new measures to open the bond market to foreign investors, aiming to enhance the liquidity of RMB bonds [3] - The Hong Kong Monetary Authority plans to expand offshore RMB repurchase operations, enhancing market liquidity and supporting the development of the Hong Kong bond market [4] Company News - Shentong Express has partnered with Cainiao to advance the application of unmanned vehicles in last-mile delivery, aiming to enhance its smart delivery network [6] - Huawei has announced a new patent for an auxiliary driving method, which aims to improve drivers' perception of surrounding obstacles [6] - JD.com has launched a "Double Hundred Plan" to invest over 10 billion yuan to support quality merchants, enhancing their online sales capabilities [6] Market Review - The textile and apparel industry saw a 1.36% increase, while the light industry rose by 0.58%, indicating a positive trend in these sectors [11]